We demonstrated that both inflammation-driving subtypes, CCL19+ and SPARC+COL3A1+/FAP+THY+, are present in scleroderma, possibly promoting inflammation through chemotaxis and enhanced leucocyte infiltration. Here, SPARC is linked to scleroderma.